Search

Your search keyword '"Gardiner, Matthew D."' showing total 255 results
Start Over Author "Gardiner, Matthew D."
255 results on '"Gardiner, Matthew D."'

13. The Oxford Finger Nail Appearance Score - a new scoring system for fingernail deformity following paediatric finger tip trauma

Author

Jain, Abhilash, Stokes, Jamie, Gardiner, Matthew D., Cook, Jonathan A., Jones, Amy, Cooper, Cushla, Shirkey, Beverly, Sierakowski, Adam, Beard, David, Greig, Aina V.H., Dupré, Sophie, Adami, Raina Zarb, Baker, Benjamin, Fleet, Malik, Miles, Debbie, Nicholas, Rebecca, Nicola, Alexi, Plonczak, Agata, Sleiwah, Aseel, and Williams, Georgina

Published
2021
Full Text
View/download PDF

15. International Lower Limb Collaborative Paediatric subpopulation analysis (INTELLECT-P) study: multicentre, international, retrospective audit of paediatric open fractures.

Author

Allan, Anna Y, Berner, Juan E, Chan, James K, Gardiner, Matthew D, Nanchahal, Jagdeep, Jain, Abhilash, and Collaborative, INTELLECT

Subjects
SOFT tissue injuries, YOUNG adults, CHILD patients, SOFT tissue infections, PATELLA fractures, COMPOUND fractures
Abstract

The International Lower Limb Collaborative (INTELLECT) study analyzed pediatric open fractures in the lower limbs, involving 163 patients from 43 centers in 13 countries. The study found that road traffic accidents were the most common cause of injury, followed by high-energy falls. The majority of injuries were open tibial/fibula fractures. The study examined outcomes such as soft tissue infection, deep infection, non-union, and amputation. It found that patients with Gustilo-Anderson IIIB and IIIC injuries had a higher risk of wound infection and deep infection. Delay in achieving soft tissue closure beyond 72 hours after injury was associated with a greater likelihood of infection. The study also emphasized the importance of a combined ortho-plastic approach for managing soft tissue injuries in pediatric trauma cases. However, the study has limitations due to its retrospective design and limited applicability to middle- and low-income settings. [Extracted from the article]

Published
2024
Full Text
View/download PDF

17. Variation in the perioperative care of women undergoing abdominal-based microvascular breast reconstruction in the United Kingdom (The optiFLAPP Study)

Author

Gardiner, Matthew D., Giblin, Victoria, Highton, David, Jain, Abhilash, Jeevan, Ranjeet, Jhanji, Shaman, Kwasnicki, Richard M., Mosahebi, Afshin, Martin, Daniel, Sadideen, Hazim, Skillman, Joanna, Acquaah, Frank, Cato, Liam, Coventry, Daniel, Geoghegan, Luke, Iqbal, Fahad, Lim, Diana, McCaughey, Philip, Pancholi, Jay, Sinha, Yashashwi, Stanley, Guy, Twoon, Mark, Berry, Brendon, Borelli, Mimi, Chan, Victoria, Chauhan, Priyesh, Conci, Elena, Coulson, Rachael, Dreyer, Susan, Dynes, Kaitlyn, Evans, Esther, Gallagher, Stuart, Garner, Jessica, Kane, Tajinder, Lafford, George, Mena, Joanna, Nguyen, Uyen, Nowicka, Maria, Robinson, Daniel, Suresh, Reena, Tarassoli, Sam P., Teoh, Victoria, and Way, Benjamin

Published
2019
Full Text
View/download PDF

19. Variation in the provision and practice of implant-based breast reconstruction in the UK: Results from the iBRA national practice questionnaire

Author

Barnes, N.L.P., Blazeby, J.M., Branford, O.A., Conroy, E.J., Cutress, R.I., Gardiner, M.D., Holcombe, C., Jain, A., McEvoy, K., Mills, N., Mylvaganam, S., Potter, S., Skillman, J.M., Teasdale, E.M., Thrush, S., Whisker, L.J., Williamson, P.R., Tang, L., Nguyen, D., Johnson, R., Muralikrishnan, V., Chopra, S., Reid, A., Benyon, S., Murphy, C., Soliman, F., Lefemine, V., Saha, S., Ogedegbe, K., Olyinka, O.S., Dicks, J.R., Manoloudakis, N., Conroy, F., Irwin, G., McIntosh, S., Michalakis, I., Hignett, S., Linforth, R., Rathinaezhil, R., Osman, H., Anesti, K., Griffiths, M., Jacklin, R., Waterworth, A., Foulkes, R., Davies, E., Bisarya, K., Allan, A., Leon-Villapalos, J., Mazari, F.A.K., Azmy, I., George, S., Fahmy, F.S., Hargreaves, A., Seward, J., Henton, J., Collin, T., Mallon, P., Turner, J., Sarakbi, W., Athanasiou, I., Rogers, C., Youssef, M., Graja, T., Huf, S., Deol, H., Brindle, R., Gawne, S., Egbeare, D., Dash, I., Galea, M., Laws, S., Tayeh, S., Parvanta, L., Down, S., Westbroek, D., Roberts, J.W., Massey, J., Turton, P., Achuthan, R., Fawzy, M., Dickson, M., Carmichael, A.R., Akingboye, A., James, R., Kirkpatrick, K., Nael, E., Vidya, R., Thorne, A., Rostom, M., Depasquale, I., Cawthorn, S.J., Gangamihardja, T., Joglekar, S., Smith, J., Halka, A., MacMillan, D., Clark, S., Pearce, B., Mansfield, L., King, I., Hazari, A., Smith, B., Volleamere, A.J., Ferguson, D., Barnes, N., Knight, A., MacNeill, F., Conway, A., Irvine, T., Mylavaganam, S., Dunne, N., Kohlhardt, S., Hoo, C., Kirk, S., Hu, J., Ledwidge, S., Tang, S., Banerjee, D., Waheed, S., Voynov, V., Soumian, S., Henderson, J., Harvey, J., Robertson, S., Waters, R., Carbone, A., Skillman, J., Farooq, Ansar, Tafazal, H., Clarke, D., Cocker, D., Lai, L.M., Winter Beatty, J., Barkeji, M., Vinayagam, R., Mullan, M., Osborne, C., Baker, E., Piper, J., Mylvaganam, Senthurun, Conroy, Elizabeth, Williamson, Paula R., Barnes, Nicola L.P., Cutress, Ramsey I., Gardiner, Matthew D., Jain, Abhilash, Skillman, Joanna M., Thrush, Steven, Whisker, Lisa J., Blazeby, Jane M., Potter, Shelley, and Holcombe, Christopher

Published
2017
Full Text
View/download PDF

22. The TeaM (Therapeutic Mammaplasty) study: Protocol for a prospective multi-centre cohort study to evaluate the practice and outcomes of therapeutic mammaplasty

Author

Baker, Elizabeth, Kim, Baek, Rattay, Tim, Williams, Kathryn, Ives, Charlotte, Remoundos, Dennis, Holcombe, Chris, Gardiner, Matthew D., Jain, Abhilash, Sutton, Richard, Achuthan, Rajgopal, Turton, Philip, Fairbrother, Patricia, Brock, Lisa, Aggarwal, Shweta, Basu, Naren, Murphy, John, Trickey, Adam, Macmillan, R. Douglas, and Potter, Shelley

Published
2016
Full Text
View/download PDF

25. Surgical training and clinical trial involvement—the trainees’ view

Author

Bhangu, Aneel, Marriott, Paul, Nepogodiev, Dmitri, Kolias, Angelos G, Jamjoom, Aimun, Gardiner, Matthew D, McDermott, Frank D, Skerritt, Clare, Harries, Rhiannon L, Cornish, Julie, Stimpson, Amy L, Glasbey, James C, Bosanquet, Dave C, Chapman, Stephen, Shaikh, Shafaque, Taylor, Greg, Lee, Matthew, Wild, Jonathan, Mawdsley, Matt, Manning, Will, Jaunoo, Shameen, Adams, Hannah L., Blencowe, Natalie S, Smith, Jennifer A, Burdett, Clare, Gokani, Vimal J, Stather, Philip W, Haddow, James B, Symons, Nicholas R A, Ventham, Nicholas, and Nicholson, Gary

Published
2015

26. Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study

Author

Fatayer, Hiba, O'Connell, Rachel L, Bannon, Finian, Coles, Charlotte E, Copson, Ellen, Cutress, Ramsey I, Dave, Rajiv V, Gardiner, Matthew D, Grayson, Margaret, Holcombe, Christopher, Irshad, Sheeba, Irwin, Gareth W, O'Brien, Ciara, Palmieri, Carlo, Shaaban, Abeer M, Sharma, Nisha, Singh, Jagdeep K, Whitehead, Ian, Potter, Shelley, McIntosh, Stuart A, NeST Study Research Collaborative, O'Connell, Rachel L [0000-0001-5990-8142], Gardiner, Matthew D [0000-0002-8058-4186], Potter, Shelley [0000-0002-6977-312X], McIntosh, Stuart A [0000-0002-4123-9611], and Apollo - University of Cambridge Repository

Subjects
Treatment Outcome, SDG 3 - Good Health and Well-being, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, Humans, Breast Neoplasms, Female, Surgery, skin and connective tissue diseases, Mastectomy, Segmental, Neoadjuvant Therapy, United Kingdom
Abstract

Neoadjuvant chemotherapy (NACT) is increasingly being used to treat early breast cancer, and offers several advantages, including reducing the extent of breast and axillary surgery, and providing an in vivo assessment of tumour sensitivity to treatment1–4. Clinical trials have identified tumour subgroups with high rates of pCR. A pCR can be achieved in 45–90 per cent of human epidermal growth factor receptor 2-positive (HER2+) tumours and triple-negative breast cancer (TNBC), but the rate in oestrogen receptor-positive (ER+)/HER2-negative (HER2–) breast cancer remains below 10 per cent3,5. Historically, increasing pCR rates following NACT have not translated into more breast-conserving surgery (BCS), but more recent data suggest that NACT can result in surgical downstaging6.NACT use in the UK appears inconsistent, as highlighted by a recent prospective audit7. Although UK guidelines suggest considering NACT in patients with HER2+ cancers and TNBC, detailed guidance does not exist8. Furthermore, it is unclear whether pCR rates in routine clinical practice reflect those observed in trials, and whether tumour downstaging influences surgical decision-making beyond the trial setting. Moreover, there remains a lack of consensus on whether definitive surgery should aim to excise the original or post-treatment tumour footprint, as highlighted in a recent UK survey9, in which 24 per cent of centres stated that their routine practice was to excise the original tumour footprint rather than carry out response-adapted surgery.This prospective study aimed to determine surgical decision-making in the breast and axilla and pCR rates in routine clinical practice following NACT for early breast cancer.

Published
2022

31. International Lower Limb Collaborative (INTELLECT) study : a multicentre, international retrospective audit of lower extremity open fractures

Author

Berner, Juan Enrique, Chan, James K. K., Gardiner, Matthew D., Navia, Alfonso, Tejos, Rodrigo, Ortiz-Llorens, Manuel, Ortega-Briones, Alina, Rakhorst, Hinne A., Nanchahal, Jagdeep, Jain, Abhilash, Berner, Juan Enrique, Chan, James K. K., Gardiner, Matthew D., Navia, Alfonso, Tejos, Rodrigo, Ortiz-Llorens, Manuel, Ortega-Briones, Alina, Rakhorst, Hinne A., Nanchahal, Jagdeep, and Jain, Abhilash

Abstract

Sixty-two centres in 16 countries contributed with 2,694 open fractures cases to an international, multi-centric, retrospective cohort study involving different healthcare settings. The INTELLECT study results show that there are significant disparities on the management of open lower limb fractures internationally. A timely, multidisciplinary, guideline-directed care is a protective factor for developing infective complications, non-union and requiring an amputation.

Published
2022
Full Text
View/download PDF

32. International, prospective cohort study comparing non-absorbable versus absorbable sutures for skin surgery: CANVAS service evaluation.

Author

Lee, Alice, Stanley, Guy H. M., Wade, Ryckie G., Berwick, Daniele, Vinicombe, Victoria, Salence, Brogan K., Musbahi, Esra, De Poli, Anderson R. C. S., Savu, Mihaela, Batchelor, Jonathan M., Abbott, Rachel A., Gardiner, Matthew D., Wernham, Aaron, and Veitch, David

Subjects
DERMATOLOGIC surgery, PLASTIC surgery, SUTURES, ORAL surgery, MAXILLOFACIAL surgery, BASAL cell carcinoma, SUTURING
Abstract

Background: Absorbable or non-absorbable sutures can be used for superficial skin closure following excisional skin surgery. There is no consensus among clinicians nor high-quality evidence supporting the choice of suture. The aim of the present study was to determine current suture use and complications at 30 days after excisional skin surgery. Methods: An international, prospective service evaluation of adults undergoing excision of skin lesions (benign and malignant) in primary and secondary care was conducted from 1 September 2020 to 15 April 2021. Routine patient data collected by UK and Australasian collaborator networks were uploaded to REDCap©. Choice of suture and risk of complications were modelled using multivariable logistic regression. Results: Some 3494 patients (4066 excisions) were included; 3246 (92.9 per cent) were from the UK and Ireland. Most patients were men (1945, 55.7 per cent), Caucasian (2849, 81.5 per cent) and aged 75-84 years (965, 27.6 per cent). The most common clinical diagnosis was basal cell carcinoma (1712, 42.1 per cent). Dermatologists performed most procedures, with 1803 excisions (44.3 per cent) on 1657 patients (47.4 per cent). Most defects were closed primarily (2856, 81.9 per cent), and there was equipoise in regard to use of absorbable (2127, 57.7 per cent) or non-absorbable (1558, 42.2 per cent) sutures for superficial closure. The most common complications were surgical-site infection (103, 2.9 per cent) and delayed wound healing (77, 2.2 per cent). In multivariable analysis, use of absorbable suture type was associated with increased patient age, geographical location (UK and Ireland), and surgeon specialty (oral and maxillofacial surgery and plastic surgery), but not with complications. Conclusion: There was equipoise in suture use, and no association between suture type and complications. Definitive evidence from randomized trials is needed. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

33. Effectiveness of nail bed repair in children with or without replacing the fingernail: NINJA multicentre randomized clinical trial.

Author

Jain, Abhilash, Greig, Aina V. H., Jones, Amy, Cooper, Cushla, Davies, Loretta, Greshon, Akiko, Fletcher, Heidi, Sierakowski, Adam, Dritsaki, Melina, Thi Thu An Nguyen, May Ee Png, Stokes, Jamie R., Dakin, Helen, Cook, Jonathan A., Beard, David J., and Gardiner, Matthew D.

Subjects
FINGERNAILS, NAILS (Anatomy), PLASTIC surgery, CLINICAL trials, MEDICAL care costs, ARM exercises
Abstract

Background: Surgery for nail bed injuries in children is common. One of the key surgical decisions is whether to replace the nail plate following nail bed repair. The aim of this RCT was to assess the clinical effectiveness and cost-effectiveness of nail bed repair with fingernail replacement/substitution compared with repair without fingernail replacement. Methods: A two-arm 1 : 1 parallel-group open multicentre superiority RCT was performed across 20 secondary-care hospitals in the UK. The co-primary outcomes were surgical-site infection at around 7 days after surgery and cosmetic appearance summary score at a minimum of 4 months. Results: Some 451 children presenting with a suspected nail bed injury were recruited between July 2018 and July 2019; 224 were allocated to the nail-discarded arm, and 227 to the nail-replaced arm. There was no difference in the number of surgical-site infections at around 7 days between the two interventions or in cosmetic appearance. The mean total healthcare cost over the 4 months after surgery was €84 (95 per cent c.i. 34 to 140) lower for the nail-discarded arm than the nail-replaced arm (P < 0.001). Conclusion: After nail bed repair, discarding the fingernail was associated with similar rates of infection and cosmesis ratings as replacement of the finger nail, but was cost saving. Registration number: ISRCTN44551796 (http://www.controlled-trials.com). [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

36. Chlorhexidine versus povidone–iodine skin antisepsis before upper limb surgery (CIPHUR) : an international multicentre prospective cohort study

Author

Wade, Ryckie G., Bourke, Gráinne, Wormald, Justin C. R., Totty, Joshua Philip, Stanley, Guy Henry Morton, Lewandowski, Andrew, Rakhra, Sandeep Singh, Gardiner, Matthew D., Bindra, R., Sher, M., Thomas, M., Morgan, S. D. J., Hwang, B., Santucci, W., Tran, P., Kopp, L., Kunc, V., Hamdi, A., Grieve, P. P., Mukhaizeem, S. A., Blake, K., Cuggy, C., Dolan, R., Downes, E., Geary, E., Ghadge, A., Gorman, P., Jonson, M., Jumper, N., Kelly, S., Leddy, L., McMahon, M. E., McNamee, C., Miller, P., Murphy, B., O'Halloran, L., O’Shea, K., Skeens, J., Staunton, S., Timon, F., Woods, J., Cortinovis, U., Sala, L., Zingarello, V., Jusoh, M. H., Sadagatullah, A. N., Georgieva, G., Pejkova, S., Nikolovska, B., Srbov, B., Hamid, H. K. S., Mustafa, M., Abdelrahman, M., Amin, S. M. M., Bhatti, D., Rahman, K. M. A., Jumabhoy, I., Kiely, J., Kieran, I., Lo, A. C. Q., Wong, K Y., Allan, A. Y., Armes, H., Horwitz, M. D., Ioannidi, L., Masterton, G., Chu, H., Talawadekar, G. D., Tong, K. S., Chan, M., Tredgett, M., Hardie, C., Powell-Smith, E., Gilham, N., Prokopenko, M., Ahmad, R., Davies, J., Zhen, S., Dargan, D., Pinder, R. M., Koziara, M., Martin, R., Reay, E., Cochrane, E., Elbatawy, A., Green, F., Griffiths, T., Higginbotham, G., Louette, S., McCauley, G., Natalwala, I., Salt, E., Ahmed, R., Goon, P., Manton, R., Segaren, N., Cheung, G., Mahoney, R., Sen, S., Clarkson, D., Collins, M., Bolt, A., Lokanathan, P., Ng, A., Jones, G., Jones, J. W. M., Kabariti, R., Rhee, S. J., Herron, J., Kay, A., Cheung, L. K., Thomson, D., Jugdey, R. S., Yoon, H., L, Z., Southgate, J., Brennan, C., Kiani, S., Zabaglo, M., Haider, Z. A., Poulter, R., Sheik-Ali, A., Watts, A., Jemec, B., Redgrave, N., Dupley, L., Greenhalgh, M., Vella, J., Harris, H., Robinson, A. V., Dupre, S., Teelucksingh, S., Gargan, A., Hettiaratchy, S., Jain, A., Kwasnicki, R., Lee, A., Thakkar, M., Berwick, D., Ismail, N., Mahdi, M., Rodrigues, Jeremy, Liew, C., Saadya, A., Clarkson, M., Brady, C., Harrison, R., Rayner, A., Nolan, G., Phillips, B., Madhusudan, N., and HASH(0x5651c97f7e70)

Subjects
Adult, AcademicSubjects/MED00910, Chlorhexidine, Bjs/2, Antisepsis, General Medicine, Upper Extremity, Preoperative Care, Humans, Original Article, Prospective Studies, AcademicSubjects/MED00010, Child, Povidone-Iodine, RA, RD
Abstract

Introduction Surgical site infection (SSI) is the most common and costly complication of surgery. International guidelines recommend topical alcoholic chlorhexidine (CHX) before surgery. However, upper limb surgeons continue to use other antiseptics, citing a lack of applicable evidence, and concerns related to open wounds and tourniquets. This study aimed to evaluate the safety and effectiveness of different topical antiseptics before upper limb surgery. Methods This international multicentre prospective cohort study recruited consecutive adults and children who underwent surgery distal to the shoulder joint. The intervention was use of CHX or povidone–iodine (PVI) antiseptics in either aqueous or alcoholic form. The primary outcome was SSI within 90 days. Mixed-effects time-to-event models were used to estimate the risk (hazard ratio (HR)) of SSI for patients undergoing elective and emergency upper limb surgery. Results A total of 2454 patients were included. The overall risk of SSI was 3.5 per cent. For elective upper limb surgery (1018 patients), alcoholic CHX appeared to be the most effective antiseptic, reducing the risk of SSI by 70 per cent (adjusted HR 0.30, 95 per cent c.i. 0.11 to 0.84), when compared with aqueous PVI. Concerning emergency upper limb surgery (1436 patients), aqueous PVI appeared to be the least effective antiseptic for preventing SSI; however, there was uncertainty in the estimates. No adverse events were reported. Conclusion The findings align with the global evidence base and international guidance, suggesting that alcoholic CHX should be used for skin antisepsis before clean (elective upper limb) surgery. For emergency (contaminated or dirty) upper limb surgery, the findings of this study were unclear and contradict the available evidence, concluding that further research is necessary., This international study recruited 2454 children and adults undergoing surgery on their upper limb (arm or hand), from 42 hospitals worldwide. The overall risk of infection after surgery was 3.5 per cent. Before planned (elective) surgery, if surgeons cleaned the skin with alcoholic chlorhexidine, then the risk of infection was reduced by 70 per cent.

Published
2021

38. Variants in ALDH1A2 reveal an anti-inflammatory role for retinoic acid and a new class of disease-modifying drugs in osteoarthritis.

Author

Zhu, Linyi, Kamalathevan, Pragash, Koneva, Lada A., Zarebska, Jadwiga Miotla, Chanalaris, Anastasios, Ismail, Heba, Wiberg, Akira, Ng, Michael, Muhammad, Hayat, Walsby-Tickle, John, McCullagh, James S.O., Watt, Fiona E., Sansom, Stephen N., Furniss, Dominic, Gardiner, Matthew D., Vincent, Tonia L., Riley, Nick, Spiteri, Michelle, McNab, Ian, and Little, Christopher

Subjects
TRETINOIN, KNEE joint, ARTICULAR cartilage, PEROXISOME proliferator-activated receptors, HAND osteoarthritis, OSTEOARTHRITIS
Abstract

More than 40% of individuals will develop osteoarthritis (OA) during their lifetime, yet there are currently no licensed disease-modifying treatments for this disabling condition. Common polymorphic variants in ALDH1A2, which encodes the key enzyme for synthesis of all-trans retinoic acid (atRA), are associated with severe hand OA. Here, we sought to elucidate the biological significance of this association. We first confirmed that ALDH1A2 risk variants were associated with hand OA in the U.K. Biobank. Articular cartilage was acquired from 33 individuals with hand OA at the time of routine hand OA surgery. After stratification by genotype, RNA sequencing was performed. A reciprocal relationship between ALDH1A2 mRNA and inflammatory genes was observed. Articular cartilage injury up-regulated similar inflammatory genes by a process that we have previously termed mechanoflammation, which we believe is a primary driver of OA. Cartilage injury was also associated with a concomitant drop in atRA-inducible genes, which were used as a surrogate measure of cellular atRA concentration. Both responses to injury were reversed using talarozole, a retinoic acid metabolism blocking agent (RAMBA). Suppression of mechanoflammation by talarozole was mediated by a peroxisome proliferator–activated receptor gamma (PPARγ)–dependent mechanism. Talarozole was able to suppress mechano-inflammatory genes in articular cartilage in vivo 6 hours after mouse knee joint destabilization and reduced cartilage degradation and osteophyte formation after 26 days. These data show that boosting atRA suppresses mechanoflammation in the articular cartilage in vitro and in vivo and identifies RAMBAs as potential disease-modifying drugs for OA. Keeping osteoarthritis from getting out of hand: Keeping osteoarthritis from getting out of handOsteoarthritis (OA) is a debilitating medical condition with no treatments currently available. Here Zhu et al. identify variants in the ALDH1A2 gene, responsible for the synthesis of all-trans retinoic acid (atRA), in patients with severe hand OA and link risk alleles to cartilage injury and inflammation. They then show that administration of a retinoic acid metabolism blocking agent (RAMBA), talarozole, reduced cartilage injury and inflammation through a peroxisome proliferator–activated receptor gamma (PPARγ)–dependent mechanism in both mouse and pig joints in vivo and ex vivo, respectively. These results implicate atRA in the development of OA and suggest that RAMBAs may be a viable therapeutic option for the treatment of this disease. —AW [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

48. 07. The iBRANET localisation study; A National cohort study of wire-guided and Magseed-guided localisation for impalpable breast lesions

Author

Dave, Rajiv, primary, Elgammal, Suzanne, additional, Barrett, Emma, additional, Barnes, Nicola, additional, Sami, Amtul, additional, Masudi, Tahir, additional, Down, Sue, additional, Holcombe, Chris, additional, Potter, Shelley, additional, Somasundaram, Santosh K., additional, Gardiner, Matthew D., additional, Maxwell, Anthony J., additional, Mylvaganam, Senthurun, additional, and Harvey, James, additional

Published
2021
Full Text
View/download PDF

49. JHS909753 Supplemental Material5 - Supplemental material for Basal thumb osteoarthritis surgery improves health state utility irrespective of technique: a study of UK Hand Registry data

Author

Lane, Jennifer C. E., Rodrigues, Jeremy N., Furniss, Dominic, Burn, Edward, Poulter, Robert, and Gardiner, Matthew D.

Subjects
FOS: Clinical medicine, 110323 Surgery, 110604 Sports Medicine, FOS: Health sciences, 110314 Orthopaedics
Abstract

Supplemental material, JHS909753 Supplemental Material5 for Basal thumb osteoarthritis surgery improves health state utility irrespective of technique: a study of UK Hand Registry data by Jennifer C. E. Lane, Jeremy N. Rodrigues, Dominic Furniss, Edward Burn, Robert Poulter and Matthew D. Gardiner in Journal of Hand Surgery (European Volume)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results